Posted by linkadge on July 20, 2018, at 11:47:26
In reply to abilify/rexulti, posted by joe f on July 19, 2018, at 18:02:49
Abilify was a bit of a game changer (i.e. offered something that other APs weren't doing).
It had activity at 5-t1a and partial agonist activity at dopamine receptors (perhaps causing less dysphoria).
On paper, I don't see any major advantage of rexulti vs abilify.
Linkadge
poster:linkadge
thread:1099721
URL: http://www.dr-bob.org/babble/20180521/msgs/1099746.html